Cite
HARVARD Citation
Lepone, L. et al. (n.d.). Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells. Journal for immunotherapy of cancer. p. . [Online].